{
  "id": 268,
  "text": "Adenocarcinoma in situ.Stratified mucin-producing intraepithelial lesion.Minimum distance of uninvolved cervical stroma Margin status (invasive and preinvasive diseases).Specify the margin(s) LNs status (SLN status, number involved/number retrieved and presence of extranodal extension) Pathologically confirmed distant metastases</td></tr></table></body></html> # 8 Staging # 8.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Adenocarcinoma in situ.Stratified mucin-producing intraepithelial lesion.Minimum distance of uninvolved cervical stroma Margin status (invasive and preinvasive diseases).Specify the margin(s) LNs status (SLN status, number involved/number retrieved and presence of extranodal extension) Pathologically confirmed distant metastases</td></tr></table></body></html> # 8 Staging # 8.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈癌分期的病理学评估应关注以下因素：\n\n1. **腺癌原位（Adenocarcinoma in situ）**：需明确是否存在原位腺癌的病理证据。\n2. **分层黏液生成上皮内病变（Stratified mucin-producing intraepithelial lesion）**：观察此类病变是否存在，以评估病灶的特点。\n3. **未受累宫颈间质的最小距离**：评估肿瘤浸润区域与健康宫颈间质的距离，可反映肿瘤的局部扩展情况。\n4. **切缘状态（Margin status）**：\n   - 对侵袭性疾病（invasive disease）和非侵袭性疾病（preinvasive disease）均需要确认切缘的清除情况；\n   - 指定涉及的切缘部位，明确是否存在肿瘤残留。\n5. **淋巴结状态（LNs status）**：\n   - 包括前哨淋巴结（SLN）的状态；\n   - 检查受累淋巴结的数量、总检取数量；\n   - 是否存在淋巴结外扩展（extranodal extension）。\n6. **远处转移**：需明确是否存在病理学确认的远处转移（pathologically confirmed distant metastases）。\n\n这些病理学因素对于宫颈癌的准确分期以及治疗方案的制订具有关键意义。",
  "query": "如果需要根据描述进行诊断评估宫颈癌的分期，应考虑哪些病理学因素？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 如果需要根据描述进行诊断评估宫颈癌的分期，应考虑哪些病理学因素？\n\n<reference text>: Adenocarcinoma in situ.Stratified mucin-producing intraepithelial lesion.Minimum distance of uninvolved cervical stroma Margin status (invasive and preinvasive diseases).Specify the margin(s) LNs status (SLN status, number involved/number retrieved and presence of extranodal extension) Pathologically confirmed distant metastases</td></tr></table></body></html> # 8 Staging # 8.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈癌分期的病理学评估应关注以下因素：\n\n1. **腺癌原位（Adenocarcinoma in situ）**：需明确是否存在原位腺癌的病理证据。\n2. **分层黏液生成上皮内病变（Stratified mucin-producing intraepithelial lesion）**：观察此类病变是否存在，以评估病灶的特点。\n3. **未受累宫颈间质的最小距离**：评估肿瘤浸润区域与健康宫颈间质的距离，可反映肿瘤的局部扩展情况。\n4. **切缘状态（Margin status）**：\n   - 对侵袭性疾病（invasive disease）和非侵袭性疾病（preinvasive disease）均需要确认切缘的清除情况；\n   - 指定涉及的切缘部位，明确是否存在肿瘤残留。\n5. **淋巴结状态（LNs status）**：\n   - 包括前哨淋巴结（SLN）的状态；\n   - 检查受累淋巴结的数量、总检取数量；\n   - 是否存在淋巴结外扩展（extranodal extension）。\n6. **远处转移**：需明确是否存在病理学确认的远处转移（pathologically confirmed distant metastases）。\n\n这些病理学因素对于宫颈癌的准确分期以及治疗方案的制订具有关键意义。"
}